Your browser is no longer supported. Please, upgrade your browser.
AYTU [NASD]
Aytu Biopharma, Inc.
Index- P/E- EPS (ttm)-2.76 Insider Own6.40% Shs Outstand18.09M Perf Week-6.35%
Market Cap126.83M Forward P/E- EPS next Y-0.52 Insider Trans- Shs Float14.28M Perf Month-4.18%
Income-42.40M PEG- EPS next Q-0.31 Inst Own28.40% Short Float17.44% Perf Quarter-45.74%
Sales57.00M P/S2.23 EPS this Y91.30% Inst Trans43.29% Short Ratio3.31 Perf Half Y-17.83%
Book/sh7.91 P/B0.65 EPS next Y55.60% ROA-23.20% Target Price- Perf Year-64.41%
Cash/sh1.89 P/C2.73 EPS next 5Y- ROE-38.40% 52W Range4.86 - 17.00 Perf YTD-13.71%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-69.65% Beta-0.29
Dividend %- Quick Ratio1.00 Sales past 5Y153.90% Gross Margin50.80% 52W Low6.17% ATR0.30
Employees75 Current Ratio1.20 Sales Q/Q64.60% Oper. Margin-70.30% RSI (14)39.83 Volatility4.55% 5.30%
OptionableYes Debt/Eq0.16 EPS Q/Q6.90% Profit Margin-74.40% Rel Volume1.39 Prev Close5.33
ShortableYes LT Debt/Eq0.12 EarningsMay 17 AMC Payout- Avg Volume752.09K Price5.16
Recom1.50 SMA20-3.04% SMA50-13.75% SMA200-37.63% Volume1,046,160 Change-3.19%
Mar-30-21Initiated Cantor Fitzgerald Overweight $11
May-29-20Initiated H.C. Wainwright Buy $3
May-25-21 08:01AM  
May-17-21 04:01PM  
02:45PM  
May-15-21 03:28AM  
May-12-21 10:50AM  
May-10-21 04:01PM  
Apr-12-21 08:00AM  
Apr-05-21 08:00AM  
Apr-02-21 05:05AM  
Apr-01-21 07:30AM  
Mar-22-21 06:00AM  
Mar-18-21 05:34PM  
06:22AM  
Mar-12-21 08:00AM  
Mar-09-21 08:08AM  
Mar-08-21 03:01PM  
Feb-24-21 08:00AM  
Feb-14-21 01:41AM  
Feb-11-21 04:01PM  
Feb-10-21 08:00AM  
08:00AM  
Feb-08-21 06:57AM  
Feb-04-21 08:00AM  
Jan-06-21 07:58AM  
Dec-28-20 08:05AM  
Dec-24-20 10:49PM  
Dec-16-20 09:20PM  
Dec-15-20 12:00PM  
Dec-14-20 08:01AM  
Dec-11-20 11:41AM  
10:38AM  
Dec-10-20 11:10PM  
07:35PM  
05:35PM  
04:52PM  
08:00AM  
06:01AM  
Dec-09-20 10:30AM  
Nov-26-20 06:33PM  
Nov-12-20 04:01PM  
02:30PM  
Nov-11-20 08:00AM  
Nov-05-20 08:00AM  
Oct-06-20 05:37PM  
04:02PM  
Oct-05-20 10:05AM  
08:00AM  
Sep-23-20 06:00PM  
10:26AM  
Sep-16-20 08:00AM  
Sep-08-20 08:00AM  
Aug-19-20 08:00AM  
Aug-17-20 11:35AM  
08:00AM  
Aug-05-20 11:04AM  
Aug-04-20 11:56AM  
Jul-31-20 05:45PM  
Jul-30-20 08:00AM  
Jul-27-20 08:00AM  
Jul-20-20 07:30AM  
Jul-10-20 08:00AM  
Jul-07-20 11:30AM  
Jun-25-20 12:00PM  
08:50AM  
01:50AM  
Jun-18-20 11:30AM  
Jun-15-20 10:59AM  
Jun-12-20 08:47AM  
Jun-11-20 10:21AM  
Jun-10-20 08:37AM  
Jun-09-20 10:00AM  
08:58AM  
08:00AM  
Jun-08-20 08:00AM  
Jun-05-20 03:13PM  
Jun-03-20 08:00AM  
Jun-02-20 11:30AM  
Jun-01-20 04:01PM  
08:00AM  
May-16-20 08:40AM  
May-14-20 07:15PM  
04:01PM  
May-11-20 11:30AM  
May-07-20 05:45PM  
08:00AM  
May-05-20 05:46PM  
12:30PM  
May-01-20 09:00AM  
Apr-30-20 05:45PM  
11:45AM  
Apr-28-20 10:24AM  
Apr-27-20 12:25PM  
09:55AM  
Apr-24-20 08:00AM  
Apr-23-20 08:00AM  
Apr-22-20 11:30AM  
Apr-21-20 08:23PM  
06:30PM  
04:42PM  
08:00AM  
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. is based in Englewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARMISTICE CAPITAL, LLCDirectorDec 11Buy6.001,333,3348,000,0041,333,334Dec 15 07:17 PM